Invesco Ltd. Bio Techne Corp Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Bio Techne Corp stock. As of the latest transaction made, Invesco Ltd. holds 3,946,028 shares of TECH stock, worth $234 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,946,028

Previous 3,662,725 7.73%

Holding current value

$234 Million

Previous $188 Million 16.49%

% of portfolio

0.04%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$49.87 - $58.78 $14.1 Million - $16.7 Million	283,303 Added 7.73%	3,946,028 $220 Million
Q2 2025 Aug 13, 2025	SELL	$46.66 - $58.38 $24.6 Million - $30.8 Million	-527,390 Reduced 12.59%	3,662,725 $188 Million
Q1 2025 May 12, 2025	BUY	$58.47 - $78.75 $21.6 Million - $29.1 Million	369,651 Added 9.68%	4,190,115 $246 Million
Q4 2024 Feb 13, 2025	BUY	$66.37 - $78.17 $23.8 Million - $28 Million	358,756 Added 10.36%	3,820,464 $275 Million
Q3 2024 Nov 12, 2024	BUY	$70.96 - $82.35 $22.1 Million - $25.6 Million	311,069 Added 9.87%	3,461,708 $277 Million

Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $1.49 Million - $2.01 Million	23,923 Added 0.77%	3,150,639 $226 Million
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $9.95 Million - $11.6 Million	150,823 Added 5.07%	3,126,716 $220 Million
Q4 2023 Feb 12, 2024	BUY	$52.83 - $78.22 $57.9 Million - $85.7 Million	1,095,081 Added 58.22%	2,975,893 $230 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $16.3 Million - $21.6 Million	241,771 Added 14.75%	1,880,812 $128 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $28.6 Million - $33.3 Million	-387,532 Reduced 19.12%	1,639,041 $134 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $13.3 Million - $16 Million	185,104 Added 10.05%	2,026,573 $150 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $113 Million - $494 Million	1,402,466 Added 319.47%	1,841,469 $153 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $14.4 Million - $20 Million	-50,991 Reduced 10.41%	439,003 $125 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $3.25 Million - $4.52 Million	10,058 Added 2.1%	489,994 $170 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $3.53 Million - $4.86 Million	-9,968 Reduced 2.03%	479,936 $208 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $16.9 Million - $19.5 Million	37,150 Added 8.21%	489,904 $253 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $54.1 Million - $65.6 Million	-121,682 Reduced 21.18%	452,754 $219 Million
Q2 2021 Aug 17, 2021	SELL	$387.35 - $450.26 $71.1 Million - $82.6 Million	-183,497 Reduced 24.21%	574,436 $259 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $7.78 Million - $10.2 Million	24,725 Added 3.37%	757,933 $289 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $5.72 Million - $7.46 Million	23,186 Added 3.27%	733,208 $233 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $35.1 Million - $42.8 Million	-151,139 Reduced 17.55%	710,022 $176 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $34.1 Million - $51.4 Million	183,869 Added 27.15%	861,161 $227 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $58.1 Million - $79.8 Million	-360,314 Reduced 34.73%	677,292 $128 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $4.03 Million - $4.72 Million	21,267 Added 2.09%	1,037,606 $228 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $8.78 Million - $10.4 Million	-47,857 Reduced 4.5%	1,016,339 $199 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $98.9 Million - $113 Million	524,216 Added 97.08%	1,064,196 $222 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $1.87 Million - $2.75 Million	-13,722 Reduced 2.48%	539,980 $107 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $73.5 Million - $113 Million	553,702 New	553,702 $80.1 Million

Others Institutions Holding TECH

# of Institutions

649

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account